Literature DB >> 9294667

Direct conversion of atrial flutter to sinus rhythm with low-output, short-duration transesophageal atrial pacing.

H Ajisaka1, T Hiraki, H Ikeda, I Kubara, T Yoshida, M Ohga, T Imaizumi.   

Abstract

BACKGROUND AND HYPOTHESIS: Transesophageal atrial pacing (TAP) is useful for terminating paroxysmal non-self terminating atrial flutter (PAF); however, high output pacing of long stimulus duration causes severe symptoms such as chest pain. The objective of this study was to investigate the effect of low-output, short-duration TAP on the conversion of PAF.
METHODS: We applied low-output (within 15 mA with a pulse duration of 10 ms), short-duration (within 4 s) TAP in 31 patients (50 +/- 19 years) with PAF. Transesophageal pacing was delivered with 10 pulses of burst pacing at intervals that were 20 ms shorter than those of the flutter wave length. When the conversion was unsuccessful, we delivered 20 pulses of burst pacing.
RESULTS: Sixteen patients (52%) were converted directly to sinus rhythm and 12 (38%) to atrial fibrillation. Transesophageal pacing was ineffective in 3 (10%) patients. The duration of atrial flutter, maximum flutter wave amplitude, effective pacing intervals, underlying heart diseases, and cardiac function were not different between patients who had direct conversion to sinus rhythm and those converted to atrial fibrillation. The patients who had direct conversion to sinus rhythm had longer flutter wave cycle lengths than those converted to atrial fibrillation (248 vs. 221 ms, p < 0.005). No patient had complications and complained of any symptoms.
CONCLUSION: Low-output, short-duration TAP was useful to convert PAF directly to sinus rhythm without side effects.

Entities:  

Mesh:

Year:  1997        PMID: 9294667      PMCID: PMC6656004          DOI: 10.1002/clc.4960200910

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  18 in total

1.  EXPERIENCE WITH "CARDIOVERSION" OF ATRIAL FIBRILLATION AND FLUTTER.

Authors:  J J MORRIS; Y KONG; W C NORTH; H D MCINTOSH
Journal:  Am J Cardiol       Date:  1964-07       Impact factor: 2.778

2.  EVALUATION OF COUNTERSHOCK TREATMENT OF ATRIAL FLUTTER. WITH SPECIAL REFERENCE TO ARRHYTHMIAS RELATED TO THIS PROCEDURE.

Authors:  A CASTELLANOS; A GOSSELIN; E J FONSECA
Journal:  Arch Intern Med       Date:  1965-04

3.  Characterization of atrial flutter. Studies in man after open heart surgery using fixed atrial electrodes.

Authors:  J L Wells; W A MacLean; T N James; A L Waldo
Journal:  Circulation       Date:  1979-09       Impact factor: 29.690

4.  Transesophageal atrial pacing using a pill electrode for the termination of atrial flutter.

Authors:  R H Falk; M Werner
Journal:  Chest       Date:  1987-07       Impact factor: 9.410

5.  Demonstration of an area of slow conduction in human atrial flutter.

Authors:  B Olshansky; K Okumura; P G Hess; A L Waldo
Journal:  J Am Coll Cardiol       Date:  1990-12       Impact factor: 24.094

6.  Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents.

Authors:  W Spinelli; B F Hoffman
Journal:  Circ Res       Date:  1989-12       Impact factor: 17.367

7.  Prospective evaluation of transesophageal pacing for the interruption of atrial flutter.

Authors:  W Crawford; V J Plumb; A E Epstein; G N Kay
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

8.  Transesophageal atrial pacing: a first-choice technique in atrial flutter therapy.

Authors:  M Guarnerio; F Furlanello; M Del Greco; G Vergara; G Inama; M Disertori
Journal:  Am Heart J       Date:  1989-06       Impact factor: 4.749

9.  Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap.

Authors:  H Inoue; T Yamashita; A Nozaki; T Sugimoto
Journal:  J Am Coll Cardiol       Date:  1991-10       Impact factor: 24.094

10.  Atrial pacing for conversion of atrial flutter.

Authors:  M L Greenberg; T A Kelly; B B Lerman; J P DiMarco
Journal:  Am J Cardiol       Date:  1986-07-01       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.